These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
176 related articles for article (PubMed ID: 25354760)
1. Immediate and midterm outcomes following primary PCI with bioresorbable vascular scaffold implantation in patients with ST-segment myocardial infarction: insights from the multicentre "Registro ABSORB Italiano" (RAI registry). Ielasi A; Cortese B; Varricchio A; Tespili M; Sesana M; Pisano F; Loi B; Granata F; Moscarella E; Silva Orrego P; La Vecchia L; Steffenino G; EuroIntervention; 2015 Jun; 11(2):157-62. PubMed ID: 25354760 [TBL] [Abstract][Full Text] [Related]
2. Clinical Comparison With Short-Term Follow-Up of Bioresorbable Vascular Scaffold Versus Everolimus-Eluting Stent in Primary Percutaneous Coronary Interventions. Cortese B; Ielasi A; Romagnoli E; Varricchio A; Cuculo A; Loi B; Pisano F; Corrado D; Sesana M; La Vecchia L; Summaria F; Tespili M; Silva Orrego P; Tognoni G; Steffenino G Am J Cardiol; 2015 Sep; 116(5):705-10. PubMed ID: 26100584 [TBL] [Abstract][Full Text] [Related]
3. Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry. Kraak RP; Hassell ME; Grundeken MJ; Koch KT; Henriques JP; Piek JJ; Baan J; Vis MM; Arkenbout EK; Tijssen JG; de Winter RJ; Wykrzykowska JJ EuroIntervention; 2015 Feb; 10(10):1160-8. PubMed ID: 25136885 [TBL] [Abstract][Full Text] [Related]
4. Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry. Capodanno D; Gori T; Nef H; Latib A; Mehilli J; Lesiak M; Caramanno G; Naber C; Di Mario C; Colombo A; Capranzano P; Wiebe J; Araszkiewicz A; Geraci S; Pyxaras S; Mattesini A; Naganuma T; Münzel T; Tamburino C EuroIntervention; 2015 Feb; 10(10):1144-53. PubMed ID: 25042421 [TBL] [Abstract][Full Text] [Related]
5. Initial experience with everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with acute myocardial infarction: a propensity-matched comparison to metallic drug eluting stents 18-month follow-up of the BVS STEMI first study. Fam JM; Felix C; van Geuns RJ; Onuma Y; Van Mieghem NM; Karanasos A; van der Sijde J; De Paolis M; Regar E; Valgimigli M; Daemen J; de Jaegere P; Zijlstra F; Diletti R EuroIntervention; 2016 May; 12(1):30-7. PubMed ID: 27173859 [TBL] [Abstract][Full Text] [Related]
6. Clinical findings after bioresorbable vascular scaffold implantation in an unrestricted cohort of patients with ST-segment elevation myocardial infarction (from the RAI registry). Moscarella E; Ielasi A; Varricchio A; De Angelis MC; Loi B; Tarantini G; Calabrò P; Cortese B; Mazzarotto P; Gabrielli G; Pisano F; Facchin M; Misuraca L; Lucci V; Gistri R; Tumminello G; Moretti L; Colombo A; Durante A; Fineschi M; Piraino D; Ferrario M; Coscarelli S; Nicolino A; Tespili M; Corrado D; Steffenino G Int J Cardiol; 2018 May; 258():50-54. PubMed ID: 29429635 [TBL] [Abstract][Full Text] [Related]
7. Outcome of everolimus eluting bioabsorbable vascular scaffold (BVS) compared to non BVS drug eluting stent in the management of ST-segment elevation myocardial infarction (STEMI) - A comparative study. Chakraborty R; Patra S; Banerjee S; Pande A; Khan A; Mandol PC; Ghosh D; De SK; Das SS; Nag R Cardiovasc Revasc Med; 2016; 17(3):151-4. PubMed ID: 26905052 [TBL] [Abstract][Full Text] [Related]
8. Arterial healing following primary PCI using the Absorb everolimus-eluting bioresorbable vascular scaffold (Absorb BVS) versus the durable polymer everolimus-eluting metallic stent (XIENCE) in patients with acute ST-elevation myocardial infarction: rationale and design of the randomised TROFI II study. Räber L; Onuma Y; Brugaletta S; Garcia-Garcia HM; Backx B; Iñiguez A; Okkels Jensen L; Cequier-Fillat À; Pilgrim T; Christiansen EH; Hofma SH; Suttorp M; Serruys PW; Sabaté M; Windecker S EuroIntervention; 2016 Jul; 12(4):482-9. PubMed ID: 26342471 [TBL] [Abstract][Full Text] [Related]
9. Everolimus-eluting bioresorbable vascular scaffolds for treatment of patients presenting with ST-segment elevation myocardial infarction: BVS STEMI first study. Diletti R; Karanasos A; Muramatsu T; Nakatani S; Van Mieghem NM; Onuma Y; Nauta ST; Ishibashi Y; Lenzen MJ; Ligthart J; Schultz C; Regar E; de Jaegere PP; Serruys PW; Zijlstra F; van Geuns RJ Eur Heart J; 2014 Mar; 35(12):777-86. PubMed ID: 24394380 [TBL] [Abstract][Full Text] [Related]
10. Registro Absorb Italiano (BVS-RAI): an investigators-owned and -directed, open, prospective registry of consecutive patients treated with the Absorb™ BVS: study design. Cortese B; Ielasi A; Varricchio A; Tarantini G; LaVecchia L; Pisano F; Facchin M; Gistri R; D'Urbano M; Lucci V; Loi B; Tumminello G; Colombo A; Limbruno U; Nicolino A; Calzolari D; Tognoni G; Defilippi G; Buccheri D; Tespili M; Corrado D; Steffenino G; Cardiovasc Revasc Med; 2015 Sep; 16(6):340-3. PubMed ID: 26100975 [TBL] [Abstract][Full Text] [Related]
11. Everolimus-eluting bioresorbable vascular scaffold (BVS) implantation in patients with ST-segment elevation myocardial infarction (STEMI). Kajiya T; Liang M; Sharma RK; Lee CH; Chan MY; Tay E; Chan KH; Tan HC; Low AF EuroIntervention; 2013 Aug; 9(4):501-4. PubMed ID: 23687101 [TBL] [Abstract][Full Text] [Related]
12. A Prospective Evaluation of a Pre-Specified Absorb BVS Implantation Strategy in ST-Segment Elevation Myocardial Infarction: The BVS STEMI STRATEGY-IT Study. Ielasi A; Campo G; Rapetto C; Varricchio A; Cortese B; Brugaletta S; Geraci S; Vicinelli P; Scotto di Uccio F; Secco GG; Poli A; Nicolini E; Ishida K; Latib A; Tespili M JACC Cardiovasc Interv; 2017 Sep; 10(18):1855-1864. PubMed ID: 28935077 [TBL] [Abstract][Full Text] [Related]
13. A prospective evaluation of a standardized strategy for the use of a polymeric everolimus-eluting bioresorbable scaffold in ST-segment elevation myocardial infarction: Rationale and design of the BVS STEMI STRATEGY-IT study. Ielasi A; Varricchio A; Campo G; Leoncini M; Cortese B; Vicinelli P; Brugaletta S; di Uccio FS; Latib A; Tespili M Catheter Cardiovasc Interv; 2017 Jun; 89(7):1129-1138. PubMed ID: 27774758 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the Safety of Everolimus-Eluting Bioresorbable Vascular Scaffold (BVS) Implantation in Patients With Chronic Total Coronary Occlusions: Acute Procedural and Short-Term Clinical Results. Goktekin O; Yamac AH; Latib A; Tastan A; Panoulas VF; Sato K; Erdogan E; Uyarel H; Shah I; Colombo A J Invasive Cardiol; 2015 Oct; 27(10):461-6. PubMed ID: 26429848 [TBL] [Abstract][Full Text] [Related]
15. Long-term outcomes of bioresorbable vascular scaffold in ST-elevation myocardial infarction. de Hemptinne Q; Picard F; Ly HQ; Ibrahim R; Asgar AW; de Guise P; Doucet S; Dorval JF; Marquis-Gravel G; Levi M; L-L'allier P; Tanguay JF Acta Cardiol; 2018 Jun; 73(3):276-281. PubMed ID: 28954592 [TBL] [Abstract][Full Text] [Related]
16. Percutaneous coronary intervention for chronic total occlusion of the coronary artery with the implantation of bioresorbable everolimus-eluting scaffolds. Poznan CTO-Absorb Pilot Registry. Lesiak M; Łanocha M; Araszkiewicz A; Siniawski A; Grygier M; Pyda M; Olasińska-Wiśniewska A; Iwanczyk S; Skorupski W; Mitkowski P; Lesiak MB; Grajek S EuroIntervention; 2016 Jun; 12(2):e144-51. PubMed ID: 27290673 [TBL] [Abstract][Full Text] [Related]
17. Mid- to long-term outcome of patients treated with everolimus-eluting bioresorbable vascular scaffolds: Data of the BVS registry Göttingen predominantly from ACS patients. Hellenkamp K; Becker A; Gabriel YD; Hasenfuß G; Hünlich M; Jacobshagen C; Schillinger W; Schroeter MR Int J Cardiol; 2017 May; 234():58-63. PubMed ID: 28258843 [TBL] [Abstract][Full Text] [Related]